- Open Access
Frequency of Hepatitis A virus as a cause of anicteric hepatitis in children under 5 years: a common yet under-recognized cause
Egyptian Pediatric Association Gazette volume 70, Article number: 41 (2022)
Hepatitis A is the most common form of acute viral hepatitis in developing countries. In children < 6 years of age, most infections are asymptomatic, and if illness does occur, it is usually anicteric. This study aimed to determine the frequency of HAV in Egyptian children under 5 years presenting with gastroenteritis-like manifestations and to associate the frequency of HAV with social, demographic, and various risk factors.
Among 450 children aged from 6 months to 5 years of both sexes, presenting with gastroenteritis-like manifestations and anicteric hepatitis, 200/450 children had elevated transaminases (ALT, AST) and were recruited in the study. A total number of 24 (12%) out of 200 children were found to have HAV IgM antibodies. Lower maternal and paternal education, poor sanitary and hygienic conditions, crowding, contaminated water, and lack of sanitary facilities were significantly higher in HAV-positive group (p-value < 0.05). ALT and AST were significantly higher in HAV IgM-positive group (p-value < 0.01).
HAV infection is common in Egyptian children with gastroenteritis-like manifestations and anicteric hepatitis. Hepatitis A is a vaccine-preventable disease.
Hepatitis A virus (HAV) is one of the most frequent communicable diseases with an estimated 1.5 million cases diagnosed each year globally . According to World Health Organization (WHO), HAV caused around 7134 deaths in 2016, which accounts for 0.5% of the mortality due to viral hepatitis .
Hepatitis A endemicity is intimately linked to hygienic and sanitary conditions, as well as other markers of socioeconomic development. HAV infection is highly endemic in developing countries with low sanitary and hygienic conditions, household crowding, and insufficient water supply .
Egypt is situated in an area of intermediate endemicity. More than 50% of the Egyptian population are already exposed to HAV infection by the age of 15 . In Egypt, between 2001 and 2004, a sentinel surveillance revealed that the risk of HAV infection was high in Egypt’s rural areas, and that children were more prone to contact the infection (median age: 4 years). HAV infection, however, was more common among young adults in urban regions (median age: 14 years) .
Between 2014 and 2017, HAV accounted for 93.4% of all confirmed cases of acute viral hepatitis. Children under the age of 16 were most likely to contract HAV (81.8%), and the majority of patients lived in urban areas (82.8%) .
Anicteric hepatitis is a mild form of hepatitis in which there is no jaundice. Symptoms include anorexia, GI disturbance, and slight fever. Aspartate aminotransferase and alanine aminotransferase serum levels are elevated .
Anicteric hepatitis A is an important entity. It is as common as viral icteric hepatitis. Diagnosis is made much less frequently, thus contributing to spread of the disease .
Because of obscure symptoms and the absence of icterus, the infection often goes unnoticed. This study aimed to determine the frequency of HAV in children presenting with gastroenteritis-like manifestations and anicteric hepatitis in Egypt and to identify the social, demographic, and other risk factors.
This cross-sectional study was conducted at the outpatient clinic of the Cairo University Pediatric Hospital, Egypt, during the period from June 2020 to September 2020.
All parents/guardians signed an informed consent before participating in the study. The study was reviewed and approved by the Cairo University research ethics committee (REC) (MS-169-2019) in accordance with the Declaration of Helsinki.
Children are presented with acute onset of low-grade fever (< 38.5 °C), vomiting, diarrhea, nausea, malaise, abdominal pain, and normal-colored urine. Only children with elevated transaminases were recruited.
These are children with jaundice, previous history of HAV infection/vaccination, chronic liver disease, or suspected bacterial or parasitic gastroenteritis (watery/bloody diarrhea, severe dehydration, high-grade fever, frequent motions > 6/day).
Data was collected from the parents/guardians in the form of the following:
History of (icter, changing color of urine, previous isolation in fever hospital, previous abnormal liver function test)
Practice of cleaning (we examined the fingernails of the child to decide whether dirty or clean).
Maternal and paternal education which were classified as (did not complete primary, primary, secondary, or tertiary education)
Crowding (numbers of persons living the home) categorized at two levels (> 4 or ≤ 4 persons/home)
Household spaciousness (classified according to the number of the rooms (> 2 or ≤ 2)
Sanitary facilities (the presence of a flush toilet, or pit toilet, or outside house) 
Complete physical examination was performed including the following:
General examination for jaundice, finger nails (dirty or clean)
Laboratory tests in the form of liver transaminase (ALT, AST) were withdrawn for all children with gastroenteritis-like manifestations. Only children with elevated transaminases were recruited. IgM antibodies against HAV virus were only done in children with transaminitis. Anti-HAV IgM was tested using ELISA (enzyme-linked immunoassay), Bioneovan Co. Ltd., Beijing, China. Children were divided into 2 groups HAV-positive and HAV-negative groups according to the results of the HAV IgM. In the HAV-positive group, further investigations were done in the form of the following:
Complete blood picture
Prothrombin time (PT) and international normalized ratio (INR), measured as a marker of severity
The data are summarized as mean ± SD and median (IQR) and analyzed by chi-square test and/or Fisher exact test. The comparison between two independent groups with quantitative data and parametric distribution was done by using the independent sample t-test, while comparisons between nonparametric data were done using the Mann-Whitney test. The confidence interval was set to 95%, and the margin of error accepted was set to 5%. So, the p-value was considered significant as the following: p < 0.05: significant, p < 0.01: highly significant.
All statistical calculations were done using computer program IBM SPSS (Statistical Package for the Social Science; IBM Corp., Armonk, NY, USA) release 23 for Microsoft Windows.
We investigated 450 children presenting with acute onset of low-grade fever (< 38.5 °C), vomiting, diarrhea, nausea, malaise, abdominal pain, and normal-colored urine; 200/450 children had elevated transaminases (ALT, AST) and were recruited in the study. The median (range) age of the recruited children was 24 (6–60) months. Around 50% were below the age of 2 years. Males represented 52% (n = 104). Twenty-four children (12%) were seropositive for HAV IgM (9–60 months, median 35). Children more than 2 years old were significantly more infected with HAV (p ˂ 0.05). The youngest child with HAV IgM-positive antibodies was 9 months old (Table 1). Comparing HAV-positive to HAV-negative group, older children, higher maternal and paternal illiteracy, poor hygiene, higher number of persons per household, contaminated water, and poor sanitation were significantly present in HAV-positive group (Table 2).
Fever was present in all children. Vomiting was significantly present in HAV-negative group, while hepatomegaly and tender liver were significantly more in HAV-positive group (Table 3). Liver enzymes were significantly more elevated in HAV-positive group (p = 0.000) (Table 4).
We found a highly statistically significant positive correlation between the age of the children and liver enzymes (r = 0.343, 0.228, and p-value < 0.001).
Coagulopathy in the form of prolonged PT, median (IQR) 47 (34–94) s, was seen in 9 children in the HAV IgM-positive group. The median (IQR) INR of 6 of them was 4.4 (2.8–7.5) which was not corrected after vitamin K (10 mg/day) for 3-successive-day intake indicating acute liver failure.
Thrombocytopenia was found in 4 (16.7%) of HAV-positive group.
To the best of our knowledge, this is the first study in Egypt to report the frequency of HAV as a cause of anicteric hepatitis in children under the age of 5 years.
The present study showed that 12% of recruited children were infected with HAV. Children were presenting with clinical features suggestive of anicteric viral hepatitis. This is a strikingly high frequency. Undiscovered sufferers from anicteric hepatitis due to HAV infection are the primary source of HAV spread, because they are not recognized.
In a previous study from Egypt, acute HAV infection was diagnosed in 97% of children and was considered as a chief etiology in children presenting with symptomatic acute hepatitis .
Benzamin et al.  study included 161 children from Bangladesh, aged 5 months to 16 years, admitted with acute hepatitis. The most common etiology of anicteric hepatitis was Salmonella hepatitis (66.7%), followed by HAV (16.7%). Three (23%) patients died in the acute liver failure group; all were due to HAV. HAV was the most common etiology of fulminant hepatic failure in Talat et al.  study.
Among the different demographic factors we investigated, the age significantly affected the prevalence of anti-HAV IgM (p = 0.02; 0.01). Seropositivity increases in increments as age increases. Children above the age of 2 years were significantly more infected. Older children are less dependent with more outdoor play exposing them to the risk of infection. Young children infected with HAV do not have many symptoms and can even be asymptomatic. It is possible for them to have HAV infection without realizing and facilitate the silent spread of infection.
We were unable to identify a significant sex-related difference in our study which is consistent with previous studies .
Our study revealed that crowded households, lower maternal and paternal educational level, poor personal and domestic hygiene, use of piped unfiltered drinking water, and living in areas with poor infrastructure pose the greatest risks of HAV infection. Our fear is that because of vague symptoms and the absence of jaundice, the infection often passes unnoticed leading to the spread of infection.
A study from India showed that infection-induced antibodies were seen in the lower-middle socioeconomic status group .
All children (100%) in our study is presented with fever. Vomiting was present in 97% of all children and was significantly more in HAV-negative group. Kumar et al.  conducted a study in children diagnosed with acute viral hepatitis A. Jaundice was present in all the patients as this was the inclusion criteria. Fever was present in 82.1% and hepatomegaly in 98.7%. In our study, hepatomegaly was present in 5 (20.8%) of HAV-positive children.
Morad et al.  conducted an Egyptian study on 80 children with HAV infection: 50 with acute hepatitis, 12/50 presented with anicteric hepatitis, and 30 children presented with fulminant hepatic failure, and 2/30 were anicteric. They found statistically significant association between acute hepatitis A virus, fulminant hepatic failure, and low socioeconomic level and poor hygiene (P < 0.008; p = 0.04). They also reported that prolonged PT more than 25.87 s showed an increasing risk for developing fulminant hepatic failure in children with acute HAV.
In Kumar et al.  study, coagulopathy was observed in 15.4% of HAV-positive patients. In our study, 9 (37.5%) children of HAV-positive group fulfilled the criteria for fulminant hepatic failure diagnosis. This biochemical evidence of acute liver injury (< 8-week duration), no evidence of chronic liver illness, and hepatic-based coagulopathy are defined as a PT > 20 s or INR > 2 regardless of the presence of clinical hepatic encephalopathy. Due to the nature of this cross-sectional study, no follow-up data is available.
Our study recommends compulsory HAV vaccination due to the possible occurrence of fulminant hepatic failure in anicteric children. The absence of jaundice may delay the diagnosis of HAV infection in young children.
In the present study, thrombocytopenia was found in 16.7% of children with positive HAV IgM. Cheema et al.  found thrombocytopenia in 10% of the patients; 22.1% were less than 5 years of age. Thrombocytopenia improved in all patients spontaneously. The authors could not find any evidence of disseminated intravascular coagulation or bone marrow suppression. It is reported that immune thrombocytopenic purpura may be the only symptom of acute hepatitis A, with no accompanying symptoms such as jaundice, vomiting, or stomach pain . Shenoy et al.  also reported a case of child with severe thrombocytopenia as an initial manifestation of acute HAV infection.
At 12 months, the recommended age for HAV vaccination, Arankalle et al.  found in their study that infants had the lowest IgG antibody prevalence. The infants who belong to lower- middle socioeconomic status had a reduced HAV exposure as a result of improved hygiene and targeted immunization policies. The authors emphasized the need of HAV vaccination regardless of socioeconomic background.
The youngest age of infection with HAV in the current study was 9 months. We recommend receiving the vaccine at the age of 9 months in areas with high prevalence, driven by the need to provide protection before the infant is likely to be exposed to infection, to reduce the potential for the development of severe complications, and to limit the spread of disease in which the diagnosis may be missed. Infants will still need routine vaccination after the first birthday due to passively acquired maternal antibody. In certain countries (USA), infants aged 6–11 months traveling to countries with high or intermediate endemic HAV receive a vaccine dose and are revaccinated with 2 doses, separated by at least 6 months, between age 12–23 months .
Our study highlights the fact that the real extent of hepatitis A among anicteric children is not well known and shows unexpected prevalence among children presenting with vague gastrointestinal symptoms.
Limitations of the study
This study is cross sectional with no long-term follow-up of the HAV-positive group. We could not evaluate the etiology of anicteric hepatitis in the HAV-negative group to give a better estimate of the various causes of this condition in Egypt. Another limitation is that the viral load of HAV was not quantified by PCR to correlate its level with the disease severity.
In Egypt, anicteric hepatitis due to HAV infection is not uncommon. The frequency of HAV infection in children less than 5 years presenting with anicteric hepatitis was 12%. Risk factors associated with HAV infection were older age, crowded environment, lower maternal and paternal educational level, poor sanitary and hygienic conditions, use of contaminated drinking water, and living in areas with poor infrastructure. Our study highlights the need for increased public awareness of the disease, improved sanitation, water supply, hygiene, and adding HAV vaccination to mandatory vaccines in Egypt. We recommend starting HAV vaccination early at 9–12 months in areas with high endemicity, such as Egypt, to provide protection before exposure, to limit the disease spread caused by missed diagnosis, and to reduce incidence of potentially fatal complications.
Availability of data and materials
Data will be made available by the corresponding author to the editor after a request email from the editor. The reason for sharing the data should be justified, and it will be shared after all the authors approve the same.
Hepatitis A virus
Arankalle V, Tiraki D, Kulkarni R, Palkar S, Malshe N, Lalwani S, Mishra A (2019) Age-stratified anti-HAV positivity in Pune, India after two decades: has voluntary vaccination imp age acted overall exposure to HAV? J Viral Hepat 26:757–760
Benzamin SM, Khadga M, Nahid KL, Rukunuzzaman MW, Fahmida Begum F, Islam S, Kibtiar M, Karim B (2019) Acute hepatitis in children: experience at a tertiary. Pak Pediatr J 43:265–269
CDC, 2021. Available at: https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf Acessed on 25/8/2021
Ceran N, Yüksel Kocdogan F, Mert D, Erdem I, Dede B, Adaleti R, Ozyürek S, Karagül E, Göktaş P (2012) Hepatitis A seroprevalence in children and young adults in Istanbul, Turkey: seroprevalence change and associated factors. J Viral Hepat 19:72–76
Cheema H, Fayyaz Z, Parkash A, Malik H (2014) Atypical presentation of Hepatitis A in children prsenting to the children hospital Lahore, Pakistan. Infect Dis J Pak 23(4);763–7
Fouad HM, Reyad EM, El-Din AG (2018) Acute hepatitis A is the chief etiology of acute hepatitis in Egyptian children: a single-center study. Eur J Clin Microbiol Infect Dis 37:1941–1947
Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L (2012) Hepatitis A epidemiology and prevention in developing countries. World J Hepatol 4:68–73
Harris P, Nagy S, Vardaxis N (2019) Mosby’s Dictionary of Medicine, Nursing and Health Professions-Australian & New Zealand Edition-eBook, 3rd. By Peter Harris, Sue Nagy, Nicholas Vardaxis.
Kroneman A, de Sousa R, Verhoef L, Koopmans MPG, Vennema H (2018) Usability of the international HAV Net hepatitis A virus database for geographical annotation, backtracing and outbreak detection. Euro Surveill 23:1–9
Kumar KJ, Kumar HK, Manjunath VG, Anitha C, Mamatha S (2014) Hepatitis A in children-clinical course, complications and laboratory profile. Indian J Pediatr 81:15–19
Lanini S, Minosse C, Vairo F, Garbuglia A, Di Bari V, Agresta A, Rezza G, Puro V, Pendenza A, Loffredo MR, Scognamiglio P (2017) A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016-March 2017. PLoS One 12:e0185428
Morad W, Rashed S, Allam A (2013) Factors predicting fulminant course of acute hepatitis A with special emphasis on predictors of mortality in Egyptian children. Glob Adv Res J Med Med Sci 2:184–189
Shenoy R, Nair S, Kamath N (2004) Thrombocytopenia in hepatitis A--an atypical presentation. J Trop Pediatr 50:241–242
Shouval D (2020) The history of hepatitis A. Clin Liver Dis (Hoboken) 16:12–23
Talaat M, Afifi S, Reaves E, Abu Elsood H, El-Gohary A, Refaey S, Hammad R, Abdel Fadeel M, Kandeel A (2019) Evidence of sustained reductions in the relative risk of acute hepatitis B and C virus infections, and the increasing burden of hepatitis a virus infection in Egypt: comparison of sentinel acute viral hepatitis surveillance results, 2001-17. BMC Infect Dis 19(159). https://doi.org/10.1186/s12879-019-3806-9
Talaat M, El-Sayed N, Kandeel A et al (2010) Sentinel surveillance for patients with acute hepatitis in Egypt, 2001-04. East Mediterr Health J 16:134–140
Talat S, Khan SA, Javed N, Malik MI (2020) Etiology, clinical presentation, and outcome of children with fulminant hepatic failure: experience from a tertiary center in Pakistan. Pak J Med Sci 36:1252–1256
Tanaka J (2000) Hepatitis A shifting epidemiology in Latin America. Vaccine 18:57–60
Tanir G, Aydemir C, Tuygun N, Kaya O, Yarali N (2005) Immune thrombocytopenic purpura as sole manifestation in a case of acute hepatitis A. Turk J Gastroenterol 16:217–219
Tanir G, Kiliçarslan F, Göl N, Arslan Z (2003) Age-specific seroprevalence and associated risk factors for hepatitis A in children in Ankara, Turkey. J Ankara Med School 12:81–88
Wasley A, Kruszon-Moran D, Kuhnert W, Simard EP, Finelli L, McQuillan G, Bell B (2010) The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 202:192–201
World Health Organization (2019) Hepatitis virus A Fact Sheet
Ethics approval and consent to participate
The study was reviewed and approved by the Cairo University research ethics committee (REC) (MS-169-2019). Informed written consent has been taken. Ethical statement was mentioned in method section.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Yassin, N.A., El-Houchi, S.Z., Abd El-Shafy, S.F. et al. Frequency of Hepatitis A virus as a cause of anicteric hepatitis in children under 5 years: a common yet under-recognized cause. Egypt Pediatric Association Gaz 70, 41 (2022). https://doi.org/10.1186/s43054-022-00134-x
- Hepatitis A
- Developing countries
- Anti-HAV IgM